Therapeutically Active
Digital Medicine

We’re creating digital neurological treatments engineered to directly improve cognitive deficits. Our treatments look and feel like high-end interactive action video games but, unlike typical video games, they are designed with proprietary technology engineered to target cognitive deficits at the specific sources in the brain to improve cognitive function.

 
 

Explore the science and technology behind Akili’s digital treatments

Developed through the collaboration of world-renowned cognitive neuroscientists and acclaimed entertainment and technology designers, Akili has created a proprietary technology platform that represents an entirely new category of medicine.

Built on extensive peer-reviewed research, Akili’s products are designed to deliver sensory and motor stimuli to selectively target and activate specific cognitive neural systems in the brain. The proprietary technology is engineered to directly generate physiological changes in the brain to improve cognitive function.

 
 
 
 

A pioneering approach

We strive to make treatments that are not just engaging, but captivating to the point that, in the moment, patients forget they are taking medicine.

Our prescription digital medicine is delivered through creative and immersive action video game experiences to keep patients engaged and immersed in the treatment. Our products leverage the fun, deep engagement, and rewards that make games incredibly compelling but, unlike typical video games, this personalized gameplay experience is engineered with adaptive algorithms designed to treat a disease or disorder.

 

Our core technologies

 
 
 

Selective Stimulus Management (SSME™) engine 

  • Prefrontal cortex-based cognitive control, via interference processing (multitasking).

  • Key functional dependency for attention, working memory & executive function.

  • Major disorders suffer from inability to process, filter & respond to competing stimuli

 
 

Spatial Navigation (SNAV™) engine

  • In Development - details pending

 
 

Affective (AAFF™) engine

  • In Development - details pending

 
 

The Akili difference

 
 

Direct therapeutic activity

Our products are engineered with patented technology to directly access the neurological systems responsible for certain cognitive functions and generate physiological changes in the brain to improve cognitive deficits.

 
 

Adaptive, personalized treatment

Our treatments are engineered with adaptive algorithms in a closed-loop system to automatically adjust the level – or dose – for a personalized treatment experience. Second by second monitoring of patient progress enables continuous assessment and compliance tracking for clinicians and caregivers.

 
 

Captivating experience

We aim to make medicine that is not just fun and engaging, but captivating to the point that, in the moment, patients forget they are taking medicine. Our team includes award-winning video game developers that design experiences to rival some of the world’s leading action video games.

 
 
 
 
 
 

A broad pipeline of programs

Built on our proprietary technology platforms, we are pursuing a number of potential products that are designed to directly target and activate specific neural networks in the brain to treat neurological disorders. We are currently evaluating several new technologies and advancing a broad pipeline of programs across multiple diseases and disorders where cognitive function is affected, including attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD), multiple sclerosis (MS) and various other diseases.